H

    Heart Test Laboratories Inc. Common Stock (HSCS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $3.15
    +0.12 (+3.96%)

    Market Cap: $13.65M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(9/16)
    Avg Surprise
    -28.77%

    Upcoming Estimates

    Period ending Jul 31, 2026
    EPS Consensus$-0.72
    Range$-0.72 - $-0.72
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.71+0.7%
    60d ago$-0.71+0.7%
    30d ago$-0.71+0.7%
    7d ago$-0.71+0.7%
    Current$-0.72
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Oct 31, 2026
    EPS Consensus$-0.65
    Range$-0.65 - $-0.65
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.69-6.9%
    60d ago$-0.69-6.9%
    30d ago$-0.69-6.9%
    7d ago$-0.69-6.9%
    Current$-0.65
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Oct 26EST
    		-$-0.65---
    Jul 26EST
    		-$-0.72---
    Apr 26
    Reported Jul 23
    		$-0.88$-0.73-20.55%Miss+53.2%
    Jan 26
    Reported Mar 16
    		$-0.63$-0.88+28.41%Beat+75.5%
    Oct 25
    Reported Dec 15
    		$-0.85$-1.27+33.07%Beat+62.6%
    Jul 25
    Reported Sep 11
    		$-1.58$-1.87+15.51%Beat+40.2%
    Apr 25
    Reported Jul 24
    		$-1.88$-2.14+12.15%Beat+90.0%
    Jan 25
    Reported Mar 13
    		$-2.57$-2.31-11.26%Miss+14.3%
    Oct 24
    Reported Dec 16
    		$-2.27$-2.33+2.58%Beat+85.8%
    Jul 24
    Reported Sep 12
    		$-2.64$-2.31-14.29%Miss+79.7%
    Apr 24
    Reported Jul 29
    		$-18.81$-3.00-527.00%Miss-8857.1%
    Jan 24
    Reported Mar 14
    		$-3.00$-6.00+50.00%Beat+81.3%
    Oct 23
    Reported Dec 14
    		$-16.00$-12.00-33.33%Miss+27.3%
    Jul 23
    Reported Sep 14
    		$-13.00$-14.00+7.14%Beat+32.5%
    Apr 23
    Reported Jul 18
    		$-0.21$-0.16-31.25%Miss+40.0%
    Jan 23
    Reported Mar 16
    		$-16.00$-18.33+12.71%Beat-
    Oct 22
    Reported Dec 15
    		$-22.00$-28.50+22.81%Beat-
    Jul 22
    Reported Sep 12
    		$-19.25$-18.00-6.94%Miss-
    Apr 22
    Reported Jul 29
    		$-0.35N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.80EV/EBITDA-0.14x
    Price/FCF-0.28xFCF Yield-360.91%
    Profitability
    Profit Margin0.00%Operating Margin-194787.00%
    ROE-4240.00%ROIC-205.33%
    Financial Health
    Debt/Equity1.33xInterest Coverage-15.59x
    Current Ratio1.19xQuick Ratio1.04x
    Trading Statistics
    Beta1.80Avg Volume125.06K
    52-Week High$3.8052-Week Low$1.63

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.80
    SMA 20$2.44
    SMA 50$2.51
    SMA 200$2.52
    EMA 10$2.84
    EMA 20$2.63
    EMA 50$2.45
    EMA 200$2.56

    MACD

    Line: 0.21Signal: 0.11Hist: 0.10

    ADX

    ADX: 33.0+DI: 28.7-DI: 7.0

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down8.0
    PSAR$2.42

    Bollinger Bands

    Upper Band$3.32
    Lower Band$1.57
    %B Position7150%(Upper)
    Band Width0.90

    RSI (14-Day)

    Neutral
    69.2

    Momentum Oscillators

    Stoch %K88.3
    Stoch %D86.5
    Williams %R-7.9
    ROC (10d)42.5%
    Momentum0.94
    CCI (20d)118.4
    MFI (14d)95.4

    Volatility Measures

    ATR (14d)$0.27(8.6%)
    StdDev (20d)0.44
    Hist Vol108.2%(High)

    Volume Flow

    VWAP$3.09
    OBV135.5M
    AD Line-83.2M
    CMF (20d)-0.037

    Volume Metrics

    Avg Vol (20d)128.5K
    Vol Ratio0.4x(Low)
    VWMA (20d)$2.58

    Pivot Points

    R3$3.39
    R2$3.26
    R1$3.15
    Pivot Point$3.02
    S1$2.91
    S2$2.78
    S3$2.67

    Advanced Oscillators

    TSI24.96
    Ultimate Osc61.7
    KST147.82

    Financial Data

    QuarterApr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023Jul 2023
    Total Revenue$89.49M$0$2,419$1,900$4,350$0$0$0$0$14,700$3,900$0
    Cost of Revenue$60.39M$0$33,443$760$1,880$0$0$0$9,201$4,561$1,520$0
    Gross Profit$29.11M$0$-31,024$1,140$2,470$0$0$0$-9,201$10,139$2,380$0
    Operating Expenses$39.66M$1.93M$2.04M$1.88M$1.92M$2.37M$1.99M$2.08M$1.88M$1.54M$1.57M$1.33M
    R&D$640.30M$638,575$727,026$997,206$929,091$1.03M$1.20M$1.22M$1.05M$509,507$757,303$565,632
    SG&A$9.94M$1.29M$1.35M$878,053$993,778$1.34M$786,068$850,736$833,678$1.03M$815,020$765,023
    Operating Income$-10,554,538$-1,928,940$-2,073,403$-1,874,119$-1,920,399$-2,371,472$-1,985,033$-2,075,667$-1,879,790$-1,525,382$-1,569,943$-1,330,655
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$524,731$61,509$279,534$183,688$180,852$179,477$117,598$22,526$20,937$118,445$178,438$36,260
    Income Before Tax$-9,968,029$-1,985,208$-2,350,769$-2,054,994$-2,094,330$-2,536,292$-2,082,918$-2,051,689$-1,846,164$-1,643,811$-1,748,378$-1,366,855
    Income Tax Expense$-3,683,000$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,285,029$-1,985,208$-2,350,769$-2,054,994$-2,094,330$-2,536,292$-2,082,918$-2,051,689$-1,846,164$-1,643,811$-1,748,378$-1,366,855
    EBITDA$21.98M$-1,923,699$-2,038,800$-1,839,631$-1,824,209$-2,217,898$-1,669,005$-1,887,538$-1,795,266$-1,480,842$-1,472,533$-1,303,759
    EBIT$-10,492,760$-1,923,699$-2,071,235$-1,871,306$-1,965,420$-2,356,815$-1,965,320$-2,029,163$-1,825,227$-1,525,366$-1,569,940$-1,330,595
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HSCS

    News

    HeartSciences Files 10-K, Highlights Fortitude Mining Deal

    HeartSciences Inc. filed its Form 10-K for the fiscal year ended April 30, 2026, announcing the launch of its MyoVista Insights AI-ECG product and a shift towards commercial revenue. The company also highlighted its proposed business combination with Fortitude Mining Holdings, positioning it as a significant value-creation opportunity. Spark, TipRanks’ AI Analyst, rates HSCS as Underperform due to weak financial performance and other risks, despite a "Buy" rating from another analyst with a $12 price target.

    The Globe and Mail•7/24/26•
    Neutral

    Form 4 Heart Test Laboratories Inc Unit For: 9 July By Investing.com

    This article reports on a Form 4 filing for Heart Test Laboratories Inc. on July 9th. It is a brief corporate financial news update from Investing.com. The information provided is minimal and focuses solely on the Form 4 filing date.

    Investing.com Nigeria•7/10/26•
    Somewhat-Bearish

    Form 4 Heart Test Laboratories Inc Unit For: 24 June By Investing.com

    This article from Investing.com reports on a Form 4 filing for Heart Test Laboratories Inc. related to June 24th. It appears to be a standard financial news brief announcing the filing without providing further details on its content. The article is very brief and acts more as a placeholder or headline announcement.

    Investing.com Canada•6/24/26•
    Bearish

    HeartSciences and Fortitude Announce All-Stock Merger Agreement

    HeartSciences and Fortitude Mining Holdings have agreed to an all-stock merger, forming a new Nasdaq-listed company primarily focused on Fortitude's Zcash venture mining platform. Digital Currency Group, Fortitude's current owner, is expected to hold 95% of the combined entity, while existing HeartSciences shareholders will retain approximately 5%. The deal, anticipated to close in the second half of 2026, will install Fortitude's management team and implement a dual-class equity structure, effectively shifting HeartSciences' strategic direction from medical technology to digital asset mining.

    TipRanks•6/24/26•
    Somewhat-Bearish

    Form 8K Heart Test Laboratories Inc Unit For: 23 June By Investing.com

    This article reports on a Form 8K filing by Heart Test Laboratories Inc. related to June 23. It includes a disclaimer about the high risks associated with trading financial instruments and cryptocurrencies, advising investors to be fully informed and seek professional advice.

    Investing.com South Africa•6/23/26•
    Neutral

    Frequently Asked Questions About HSCS

    Does HSCS pay dividends?
    Heart Test Laboratories Inc. Common Stock (HSCS) does not currently pay a regular dividend.
    What is HSCS's market cap?
    Heart Test Laboratories Inc. Common Stock (HSCS) has a market capitalization of $13.65M with a current stock price of $3.15.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In